Pay in 4 interest-free payments of $7.10 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
p53 tumour-suppressor caution Because FOXO4-DRI intervenes in the p53 pathway, which is critical for tumour suppression, there is theoretical concern that interfering with p53 dynamics might carry oncogenic risk
For a week, Metro Manila was abuzz with billboards announcing Luxxe Whites discontinuation, fueling speculations that the company was struggling
That gap is exactly why the compound is sold for research only
Yes it has been on the WADA Prohibited List since January 2022
The background: In September 2023, the FDA placed nineteen peptides, including BPC-157 and TB-500, into Category 2 of its 503A bulk drug substances policy, citing safety concerns
CJC 1295 provides a steady GH base, while Ipamorelin delivers pulse-like spikes
US$ 21.20
US$ 24.58
US$ 21.27
US$ 21.87
US$ 22.70
US$ 22.87
US$ 20.62
US$ 20.25
